Japan Antiphospholipid syndrome-Stroke Prevention Study
Phase 4
- Conditions
- Antiphospholipid syndrome
- Registration Number
- JPRN-C000000342
- Lead Sponsor
- JASPRES team
- Brief Summary
discontineued
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Female patients who are pregnant or plans to be pregnant Patients who cannot have warfarin or antiplatetet drugs Patients who are required to take warfarin Patients with severe hepatic, renal or cardiac failure Other inadequate patients for this clinical trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cerebral Infarct Score in MRI
- Secondary Outcome Measures
Name Time Method